FUNDAMENTALS · Fundamentals · India Healthcare

Medi Assist Health Ser L (MEDIASSIST) Fundamentals 2026 — P/E 28.5x, Revenue Analysis | SniperIQ

Medi Assist Health Ser L (MEDIASSIST) is a India-listed Healthcare company in Medical - Healthcare Information Services with a market capitalization of ₹2,601 Crore, trading at ₹348.15 on the NSE. This SniperIQ fundamentals page covers Medi Assist Health Ser L's valuation (P/E 28.5x, P/B 3.0x), profitability (net margin 9.7%), revenue (₹905 Crore in FY2026), balance-sheet quality, and AI signal context — from live market data, research only.

Market Cap₹2,601 Crore
P/E (TTM)28.5x
Net Margin9.7%
Revenue (FY26)₹905 Crore

Full research coverage

  • 8-Quarter Revenue & Margin Trend
  • Debt Maturity & Coverage
  • Peer Valuation Comparison
  • Free Cash Flow & Owner Earnings
  • AI Signal + Institutional Flow
  • DCF Valuation Model

Frequently Asked Questions

What is Medi Assist Health Ser L's market cap?

Medi Assist Health Ser L (MEDIASSIST) has a market capitalization of approximately ₹2,601 Crore, trading at ₹348.15 on the NSE. Market cap moves with the live share price.

What is Medi Assist Health Ser L's P/E ratio?

Medi Assist Health Ser L's trailing twelve-month P/E ratio is 28.5x, with a price-to-book (P/B) of 3.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.

How profitable is Medi Assist Health Ser L?

Medi Assist Health Ser L runs a net profit margin of 9.7%, a gross margin of 44.0%, and an operating margin of 10.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.

How much revenue does Medi Assist Health Ser L generate?

Medi Assist Health Ser L reported revenue of ₹905 Crore for fiscal year 2026, with net income of ₹88 Crore and earnings per share (EPS) of 12.14. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.

Does Medi Assist Health Ser L pay a dividend?

Medi Assist Health Ser L does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.

Is Medi Assist Health Ser L financially healthy?

Medi Assist Health Ser L carries a debt-to-equity ratio of 0.06x and a current ratio of 1.34x, with a market beta of 1.13. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.

Is Medi Assist Health Ser L a good stock to buy in 2026?

SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Medi Assist Health Ser L (MEDIASSIST) the key facts are: market cap ₹2,601 Crore, P/E 28.5x, revenue ₹905 Crore, 52-week range 293-594.1. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.

Track Medi Assist Health Ser L's full fundamentals live

Get Medi Assist Health Ser L's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.

Related: Mettler-Toledo International (MTD) fundamentals · Pegavision (6491) fundamentals · Aprogen Biologics (003060) fundamentals · Solara Active Pharma Sciences (SOLARA) fundamentals · All stock fundamentals · AI signal library
Research Hubs: Fundamentals library · Screeners · Institutional positioning · Super investors · Daily signals · Platform comparisons